Tailored Exercise Program Cuts Time in Atrial Fibrillation by 45 Percent in Clinical Trial

A one-year clinical trial found that a personalized exercise program reduced the time patients spent in atrial fibrillation by 45 percent, according to results reported in September 2026.

Atrial fibrillation, commonly called AFib, is the most common heart rhythm disorder in the United States. It causes the upper chambers of the heart to beat irregularly, raising the risk of stroke, heart failure, and other complications. An estimated 6 million Americans live with the condition.

The trial enrolled patients with persistent or paroxysmal AFib and assigned them to a tailored exercise regimen developed around their individual fitness levels and health status. Participants in the exercise group saw a 45 percent reduction in the proportion of time their hearts spent in AFib compared to a control group that received standard care.

Researchers said the results suggest that exercise works through multiple pathways, including reducing inflammation, lowering blood pressure, improving the function of the autonomic nervous system, and reducing obesity, all of which are known contributors to AFib.

The findings align with a broader shift in cardiology toward lifestyle interventions as a first-line or complementary treatment for heart rhythm disorders. Previous research has shown that weight loss and aerobic exercise can reduce AFib burden, but this trial is among the largest and longest to quantify the effect with a structured, individualized program.

Cardiologists not involved in the study called the results promising but noted that exercise programs need to be carefully designed for AFib patients, as some forms of very high-intensity training have been associated with increased AFib risk in certain populations.

The trial results were reported by Healthline and other medical news outlets as part of September 2026 health coverage.